首页 | 本学科首页   官方微博 | 高级检索  
     


The CSD Drug Subset: The Changing Chemistry and Crystallography of Small Molecule Pharmaceuticals
Authors:Mathew J. Bryant  Simon N. Black  Helen Blade  Robert Docherty  Andrew G.P. Maloney  Stefan C. Taylor
Affiliation:1. The Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK;2. AstraZeneca, PR&D, Silk Road Business Park, Macclesfield SK10 2NA, Cheshire;3. Pfizer Global Research and Development, Materials Science Drug Product Design, Sandwich, Kent, UK
Abstract:We report the generation and statistical analysis of the CSD drug subset: a subset of the Cambridge Structural Database (CSD) consisting of every published small-molecule crystal structure containing an approved drug molecule. By making use of InChI matching, a CSD Python API workflow to link CSD entries to the online database Drugbank.ca has been produced. This has resulted in a subset of 8632 crystal structures, representing all published solid forms of 785 unique drug molecules. We hope that this new resource will lead to improvements in targeted cheminformatics and statistical model building in a pharmaceutical setting. In addition to this, as part of the Advanced Digital Design of Pharmaceutical Therapeutics collaboration between academia and industry, we have been given the unique opportunity to run comparative analysis on the internal crystal structure databases of AstraZeneca and Pfizer, alongside comparison to the CSD as a whole.
Keywords:drug design  database(s)  drug-like property(s)  crystal structure(s)  chemometrics
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号